In conclusion, our findings indicate that FCRL3 and FCRL4 expression levels are significantly increased in patients with GD and that this phenomenon is associated with hyperthyroidism but not with thyroid autoimmunity. The gene discussed is FCRL4; the disease is hyperthyroidism.